Ads
related to: drugs, prostate cancer- FAQs
Find Answers to Commonly
Asked Questions from Patients.
- Clinical Study Results
View Clinical Study Results
and Study Data Information.
- Doctor Discussion Guide
Use This List and Come Prepared to
Discuss Options with Your Doctor.
- Starting Treatment
Learn How to Find a Specialty
Pharmacy to Obtain Treatment.
- FAQs
Search results
Radiopharma-focused Telix heats up IPO summer market with $200M offering
FierceBiotech· 2 days agoAustralian radiopharmaceuticals biotech Telix Pharmaceuticals is targeting a $200 million initial...
'Disturbing' surge in young cancers may be linked to gut health, say experts
Daily Express· 5 days agoUnhealthy lifestyles, an obesity epidemic and poor gut health are feared to be fuelling a...
New Era? 'Double Selective' Antibiotic Spares the Microbiome
Medscape· 21 hours agoA new antibiotic uses a never-before-seen mechanism to deliver a direct hit on tough-to-treat...
“Monstrous” Discovery: Scientists Identify Key to Stopping Cancer Recurrence
SciTechDaily· 4 days agoScientists have discovered that polyploid giant cancer cells, which are monstrously oversized and...
How Did Nicole Brown Simpson Die? Her Autopsy Reveals the Truth Behind Her Murder
StyleCaster· 6 days agoWhat was Nicole Brown Simpson's cause of death, officially? Here's what the autopsy report revealed...
Nucleus RadioPharma secures Series A investment from AstraZeneca
BioPharma-Reporter· 2 days agoThe investment from AstraZeneca marks a strategic move to further expand Nucleus's capabilities in developing targeted radiotherapies and theranostics, aimed at making cancer
Story from UHS: Men’s health month: It’s all about awareness, prevention, education & family
Press & Sun-Bulletin· 5 days agoEvery year, June is designated as Men’s Health Month across the country. As a man, no matter your...
...Results For Biodexa's eRapa(TM) Indicates Hope for FAP Patients Who Otherwise Have a 100%...
Morningstar· 5 days agoCARDIFF, UK / ACCESSWIRE / June 3, 2024 / Biodexa Pharmaceuticals (NASDAQ:BDRX) just announced promising phase 2 results for its newly in-licensed drug eRapa for treating ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 3 days agoFDA Approved Phase II/III Clinical Study of KPG-121 in Combination with Abiraterone as a First Line Treatment for mCRPC PR Newswire HEFEI, China, June 5, 2024 HEFEI, China, June 5, 2024 /PRNewswire/ -- Kangpu Biopharmaceuticals today announced that
Angle PLC Announces Preliminary Results
Morningstar· 3 days agoPreliminary Results for the year ended 31 December 2023COMMERCIALISATION BUILDING, WITH REVENUE MORE THAN DOUBLEDNew products and services launched; and breakthrough studies completed on combined ...
Ads
related to: drugs, prostate cancer
